Search for: "ABBOTT v. WYETH"
Results 81 - 100
of 111
Sorted by Relevance
|
Sort by Date
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense… [read post]
23 Oct 2008, 10:31 am
In the Wall Street Journal (10/21) Health Blog, Jacob Goldstein wrote, "The Journal of the American Medical Association (JAMA) has come out against the drug industry in Wyeth v. [read post]
2 Oct 2008, 12:36 pm
In Eck v. [read post]
28 Dec 2012, 1:57 pm
Walker v. [read post]
13 Jul 2011, 3:04 am
Doubtful (FDA Law Blog) US: Joint citizen petition asks FDA for clarity on off-label use manufacturer-communications (FDA Law Blog) Products Allegra (Fexofenadine) – US: Sanofi settles with Actavis in Allegra suit (Patent Docs) Aloxi (Palonosetron) – US: Roche sues Teva, Sandoz, Dr Reddy over generic Aloxi (GenericsWeb) Amrix (Cyclobenzaprine) – US: CAFC changes course, denies stay of injunction of Mylan’s generic Amrix sales: In re Cyclobenzaprine Hydrochloride… [read post]
5 Apr 2013, 1:01 pm
Abbott Laboratories, C.A. [read post]
3 Feb 2011, 2:11 pm
Wyeth, 876 N.E.2d 740, 756 (Ill. [read post]
13 May 2010, 12:27 pm
Wyeth, Inc., 2010 WL 450351 (W.D. [read post]
14 Dec 2009, 4:38 pm
Wyeth, Inc. (2008) 168 Cal.App.4th 89. [read post]
31 Dec 2015, 5:12 am
Yates v. [read post]
28 Oct 2011, 7:00 am
Wyeth, Inc., 85 Cal. [read post]
8 Jun 2012, 10:35 am
Wyeth Labs., 498 F.2d 1264, 1276 (5th Cir. 1974) omitted]. [read post]
27 Oct 2011, 4:24 am
The Supreme Court held in Wyeth v. [read post]
17 Jun 2010, 5:00 am
See Gibson v. [read post]
24 Jun 2010, 5:00 am
Abbott Laboratories, 100 F.R.D. 336 (D. [read post]
15 Mar 2008, 7:00 am
Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to adopt… [read post]
17 Sep 2009, 4:30 am
Given the size of the overdose, no alleged illegibility of the little lines on the cup could possibly have made the slightest difference in the result.What's going on in those cases is the same thing we've already commented about in the context of the big preemption cases, Wyeth v. [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
